These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 2503275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
    Chiodi F, Mathiesen T, Albert J, Parks E, Norrby E, Wahren B.
    J Immunol; 1989 Jun 01; 142(11):3809-14. PubMed ID: 2497181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Jun 01; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 5. Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.
    Mathiesen T, Broliden PA, Rosen J, Wahren B.
    Immunology; 1989 Aug 01; 67(4):453-9. PubMed ID: 2475432
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Aug 01; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G, Soldini L, Orsolini P, Razzini E, Gulminetti R, Campisi D, Chiapparoli L, Cattaneo E, Achilli G.
    Microbiologica; 1991 Jul 01; 14(3):185-94. PubMed ID: 1717811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
    Ljunggren K, Broliden PA, Morfeldt-Månson L, Jondal M, Wahren B.
    Clin Exp Immunol; 1988 Sep 01; 73(3):343-7. PubMed ID: 3208446
    [Abstract] [Full Text] [Related]

  • 10. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D, Brůcková M, Stanková M, Syrůcek L, Vojtĕchovský K, Petkov V.
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar 01; 39(2):65-73. PubMed ID: 2142624
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M, Sabahi F, Mahboudi F, Kazemnejad A.
    Saudi Med J; 2006 Jan 01; 27(1):31-6. PubMed ID: 16432590
    [Abstract] [Full Text] [Related]

  • 14. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY, Jin NY, Wang HW, Guo ZR, Fang HH, An RG, Yin Z.
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan 01; 16(1):65-8. PubMed ID: 10883279
    [Abstract] [Full Text] [Related]

  • 15. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M.
    J Clin Invest; 1994 Jun 01; 93(6):2505-13. PubMed ID: 7515393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
    Neguţ EA, Usein CR, Sfartz S, Zugun-Eloae F.
    Roum Arch Microbiol Immunol; 1999 Jun 01; 58(2):131-46. PubMed ID: 11845452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI, Wilson S, O'Toole CM, Lister CM, Saeed AM, Watkins RP, Morgan-Capner P.
    Clin Exp Immunol; 1996 Feb 01; 103(2):185-91. PubMed ID: 8565298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.